Universe Pharmaceuticals INC (UPC)
USD 3.81
(5.54%)
USD 3.81
(5.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.21 Million USD | 42.77% |
| 2022 | -7.32 Million USD | -145.74% |
| 2021 | 14.19 Million USD | 30.33% |
| 2020 | 10.61 Million USD | 2.23% |
| 2019 | 10.17 Million USD | 2.54% |
| 2018 | 10.11 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -12.05 Million USD | 0.0% |
| 2023 Q4 | -3.42 Million USD | 0.0% |
| 2023 FY | - USD | 42.77% |
| 2023 Q2 | 407.03 Thousand USD | 0.0% |
| 2022 Q4 | -9.89 Million USD | 0.0% |
| 2022 FY | - USD | -145.74% |
| 2022 Q2 | 2.99 Million USD | 0.0% |
| 2021 FY | - USD | 30.33% |
| 2021 Q2 | 9.82 Million USD | 0.0% |
| 2021 Q4 | 4.21 Million USD | 0.0% |
| 2020 Q4 | 2.65 Million USD | 0.0% |
| 2020 FY | - USD | 2.23% |
| 2020 Q3 | 2.65 Million USD | 0.0% |
| 2020 Q2 | 2.65 Million USD | 0.0% |
| 2020 Q1 | 2.65 Million USD | 4.25% |
| 2019 Q2 | 2.55 Million USD | 0.0% |
| 2019 FY | - USD | 2.54% |
| 2019 Q4 | 2.55 Million USD | 0.0% |
| 2019 Q3 | 2.55 Million USD | 0.0% |
| 2018 Q3 | 2.53 Million USD | 0.0% |
| 2018 Q4 | 2.53 Million USD | 0.0% |
| 2018 Q2 | 2.53 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 372.002% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 101.043% |
| Journey Medical Corporation | 1.92 Million USD | 267.364% |
| Dynavax Technologies Corporation | 9.66 Million USD | 133.262% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 97.858% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 97.976% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 101.974% |
| PainReform Ltd. | -9.56 Million USD | 66.401% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | 23.666% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 15.933% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 15.933% |
| SCYNEXIS, Inc. | 73.47 Million USD | 104.375% |
| Silver Spike Investment Corp. | 7.34 Million USD | 143.801% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -36.753% |
| Alpha Teknova, Inc. | -25.53 Million USD | 87.411% |
| Alvotech | -484.86 Million USD | 99.337% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 102.941% |
| Bright Green Corporation | - USD | Infinity% |
| Embecta Corp. | 245.4 Million USD | 101.31% |
| Safety Shot Inc | -12.18 Million USD | 73.615% |
| Procaps Group, S.A. | 104.02 Million USD | 103.091% |
| Cosmos Health Inc. | -17.06 Million USD | 81.156% |
| Theratechnologies Inc. | -10.31 Million USD | 68.824% |
| Harrow Health, Inc. | 9.72 Million USD | 133.067% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | 28.949% |
| Biofrontera Inc. | -18.45 Million USD | 82.577% |
| DURECT Corporation | -24.68 Million USD | 86.975% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 103.272% |
| Cronos Group Inc. | -72.14 Million USD | 95.544% |
| OptiNose, Inc. | -15.55 Million USD | 79.328% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 99.652% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 91.09% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 112.24% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 108.923% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | 18.032% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -352.285% |
| Radius Health, Inc. | 38.31 Million USD | 108.392% |
| ProPhase Labs, Inc. | -14.82 Million USD | 78.316% |
| Phibro Animal Health Corporation | 84.6 Million USD | 103.8% |
| Procaps Group S.A. | 104.02 Million USD | 103.091% |
| TherapeuticsMD, Inc. | -8.4 Million USD | 61.73% |
| Viatris Inc. | 3.51 Billion USD | 100.091% |
| Rockwell Medical, Inc. | -4.69 Million USD | 31.507% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -217.695% |
| SIGA Technologies, Inc. | 84.15 Million USD | 103.82% |
| Tilray Brands, Inc. | -72.84 Million USD | 95.586% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 495.944% |
| Shineco, Inc. | -26.55 Million USD | 87.892% |
| PetIQ, Inc. | 81.48 Million USD | 103.946% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | 11.128% |
| Incannex Healthcare Limited | -18.5 Million USD | 82.625% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 100.773% |
| Alimera Sciences, Inc. | 7.27 Million USD | 144.187% |
| Assertio Holdings, Inc. | -222.44 Million USD | 98.555% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | 19.435% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 80.867% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 83.949% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 97.844% |
| Hempacco Co., Inc. | -12.77 Million USD | 74.83% |
| Talphera, Inc. | -9.84 Million USD | 67.333% |
| Alvotech | -484.86 Million USD | 99.337% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 104.148% |
| Lantheus Holdings, Inc. | 491 Million USD | 100.655% |
| Currenc Group, Inc. | -1.9 Million USD | -69.163% |
| Kamada Ltd. | 21.53 Million USD | 114.93% |
| Indivior PLC | 66 Million USD | 104.871% |
| Evoke Pharma, Inc. | -7.29 Million USD | 55.911% |
| Flora Growth Corp. | -45.87 Million USD | 92.991% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 83.949% |
| Evolus, Inc. | -41.81 Million USD | 92.31% |
| HUTCHMED (China) Limited | 25.52 Million USD | 112.594% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 101.331% |
| Akanda Corp. | -27.73 Million USD | 88.408% |